NCT01992952 2025-11-26
FAKTION
Velindre NHS Trust
Phase 1/2 Active not recruiting
Clinical Trials
5 trialsNCT05176080 2024-12-17
Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer
Henan Cancer Hospital
Phase 1/2 Terminated
NCT05328440 2023-09-25
Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2+ Advanced Breast Cancer(DAP-Her-02)
Henan Cancer Hospital
Phase 2 Unknown
NCT03024580 2019-08-15
MEGA
Instituto Nacional de Cancer, Brazil
Phase 2 Unknown
NCT02530411 2015-08-21
FURVA
Velindre NHS Trust
Phase 2 Unknown